| URL | https://www.biopharmadive.com/news/sonoma-treg-man |
| Source | Biopharma Dive |
| Date Published | 08/24/2022 |
| Author Name | Ned Pagliarulo |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Sonoma Biotherapeutics |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2022 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 335 |
| City reshored to: | Seattle |
| State(s) reshored to: | WA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | t-cell therapies |